Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: Aehr Test Systems, 3 years.
Aehr Test Systems
Director
Credo Technology Group Holding Ltd
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Aehr Test Systems October 20, 202599.1%
-
Aehr Test Systems October 21, 202498.8%
-
Aehr Test Systems October 23, 202398.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Aehr Test Systems | Grant or award | +1,658 | — | — |
| Jun 9, 2026 | Credo Technology Group Holding Ltd | Open-market sale | −1,100 | $236.35 | $259,985 |
| May 23, 2026 | Credo Technology Group Holding Ltd | Grant or award | +890 | — | — |
| Apr 16, 2026 | Aehr Test Systems | Option exercise | +8,000 | $2.25 | $18,000 |
| Apr 16, 2026 | Aehr Test Systems | Open-market sale | −8,000 | $82.63 | $661,040 |
| Apr 13, 2026 | Aehr Test Systems | Option exercise | +7,000 | $2.25 | $15,750 |
| Apr 13, 2026 | Aehr Test Systems | Open-market sale | −7,000 | $71.49 | $500,430 |
| Apr 10, 2026 | Aehr Test Systems | Open-market sale | −3,500 | $70.05 | $245,175 |
| Oct 15, 2025 | Credo Technology Group Holding Ltd | Grant or award | +650 | — | — |
| Oct 9, 2025 | Aehr Test Systems | Open-market sale | −2,665 | $24.87 | $66,279 |
| Oct 9, 2025 | Aehr Test Systems | Open-market sale | −6,335 | $24.76 | $156,855 |
| Jul 2, 2025 | Aehr Test Systems | Grant or award | +9,253 | — | — |
| Jun 19, 2025 | Credo Technology Group Holding Ltd | Grant or award | +6,577 | — | — |
| Jul 30, 2024 | Aehr Test Systems | Open-market sale | −10,000 | $18.59 | $185,900 |
| Jul 11, 2024 | Aehr Test Systems | Grant or award | +9,265 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.